Document is current
Any future updates will be listed below
-
Authors
Steinmetz, Tilman
Jungberg, Peter
Guth, Dagmar
Knoblich, Jan
Fietz, Thomas
Göhler, Thomas
Reiser, Marcel
Totzke, Uwe
Bernhardt, Katharina
-
Funding
Funding for this research was provided by:
Accord Healthcare, Munich, Germany
- License Information
-
More Information
Article History
Received: 27 May 2025
Accepted: 15 January 2026
First Online: 25 January 2026
Declarations
:
: This observational study complied with the principles set out in the current version of the Declaration of Helsinki and was approved by the ethical committee of the Ärztekammer Nordrhein (ID 2018375). It was registered in the German Clinical Trial Register (ID DRKS00017218).
: T Steinmetz received research funding from Accord Healthcare, Amgen, Celgene/BMS, is a member of the board of directors, speaker’s bureau or advisory committee of Accord Healthcare, Amgen, BMS/Celgene, Hexal/Sandoz, Janssen-Cilag, Novartis and Pfizer. P Jungberg, D Guth, J Knoblich, T Fietz, T Göhler, M Reiser; U Totzke received honoraria by Accord Healthcare GmbH; K Bernhardt was former employee of Accord Healthcare GmbH. All remaining authors declare they have no financial interests.
